Skip to Content

Oforta Approval History

FDA Approved: Yes (Discontinued) (First approved December 18, 2008)
Brand name: Oforta
Generic name: fludarabine phosphate
Dosage form: Tablets
Company: Sanofi
Treatment for: Chronic Lymphocytic Leukemia

Marketing Status: Discontinued

Oforta (fludarabine phosphate) is an oral nucleoside analogue approved as a single agent for the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL).

Development History and FDA Approval Process for Oforta

DateArticle
Dec 19, 2008Approval Antisoma Receives FDA Approval for Oral Fludarabine, Plans Commercialization Deal to Bring Drug to US Patients
Jan 22, 2008Xanthus Announces Oral Fludarabine NDA Accepted for Review by U.S. FDA

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide